AkPharma Prelief Supplement IC/IBS Therapeutic Effect Under Study
This article was originally published in The Tan Sheet
Executive Summary
AkPharma's calcium glycerophosphate dietary supplement Prelief may have future applications for irritable bowel syndrome and other conditions exacerbated by acidic foods, according to the company.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning